Objective To assess the efficacy and safety of in-utero aspiration (IUA) 
INTRODUCTION
Fetal ovarian cysts may result from ovarian exposure to placental and maternal hormones that stimulate the ovary and cause follicle production and maturation 1 . They are most often discovered during the third trimester and resolve spontaneously after delivery, once the fetal ovary is isolated from maternal hormones. Nonetheless, complications may include intracystic hemorrhage, ovarian torsion and compression of the surrounding organs 2, 3 . Neonatal surgery, often including oophorectomy, may be necessary 4 . Only one study, published in 1985, has reported the incidence of fetal ovarian cysts; in a series of 21 000 pregnancies, eight cases of fetal ovarian cysts were identified (an incidence of 1/2600 pregnancies) 5 . Thus, despite their rarity, physicians deal with fetal ovarian cysts relatively often, and no consensus about their management is currently available 6 . One method for preventing complications is in-utero aspiration (IUA) of the ovarian cyst under ultrasound guidance [7] [8] [9] [10] [11] . Bagolan et al. performed 14 consecutive prenatal aspirations in fetuses with ovarian cysts measuring > 5 cm with no complications; of these, 12 (86%) cysts subsequently regressed, whereas two (14%) showed postnatal ultrasound signs of torsion 10 . Other authors continue to encourage conservative management, which appears to enable ovary preservation in 85% of antenatal ovarian cysts 12 . To date, no randomized trial has reported on the efficacy and safety of IUA of fetal ovarian cysts.
We conducted an open randomized controlled trial of women with female fetuses diagnosed with an anechoic ovarian cyst, to assess the efficacy of prenatal IUA in preventing neonatal surgery.
METHODS
This multicenter, prospective, randomized, open trial in two parallel groups compared prenatal IUA with expectant management of anechoic fetal ovarian cysts.
Women were recruited from nine French university hospitals. All centers were referral Level-3 maternity units in their region with an outpatient fetal medicine department. Senior physicians from each department, experienced in invasive antenatal procedures, performed all ultrasound examinations and IUA procedures.
The study was approved by the appropriate research ethics committee of the Centers' regions (Committee for the Protection of People Participating in Biomedical Research) on 28 November 2000 and by the Agence Nationale de Sécurité du Médicament et des produits en santé on 29 January 2001. The trial was registered under the number NCT00222066.
The nature of the intervention under study did not lend itself to blinding of either participants or physicians.
Selection, recruitment and randomization
The study included women with a singleton pregnancy at ≥ 28 weeks' gestation, who had a female fetus with an ultrasound-diagnosed simple ovarian cyst, defined as a single fully anechoic cystic structure measuring ≥ 30 mm and located in the lower, lateral portion of the abdomen, and with intact urinary and gastrointestinal tracts. Only women who agreed to participate in the study and provided written informed consent were included. We excluded women with multiple pregnancy, those with fetuses with morphological anomalies or bilateral, multiple or complicated ovarian cysts (mobile internal echoes, a fluid-fluid level or multiple septations), as well as women who were seropositive for HIV or hepatitis C, those with premature rupture of membranes, preterm labor, labor, pre-eclampsia, gestational diabetes requiring insulin, fetal growth restriction, or transmission of an infectious disease to the fetus. Finally, we also excluded terminations of pregnancy and cases with legal incapacity or other circumstances leading to the patient being unable to understand the nature, purpose or consequences of the study.
Randomization was computer-generated and stratified according to the maternity unit and the size of the cyst (largest diameter < 5 cm, 5-8 cm or > 8 cm). Opaque sealed envelopes containing the sequences of treatment attribution according to the randomization list were sent to each participating maternity unit. After consent was obtained, the obstetrician caring for the woman opened an envelope and allocated her randomly (1:1 ratio) to either IUA or expectant management.
Intervention
Women, with an empty stomach, were admitted to a day hospital unit. Before aspiration, the operator ensured the ovarian cyst was accessible by ultrasound examination, considering that the needle was to be inserted through the fetal anterior abdominal wall. If access to the cyst was difficult, the mother was asked to take a short walk to encourage a change in fetal position. IUA procedures took place in an operating room and involved two medical staff members from the maternal-fetal medicine department: a physician to perform the IUA and an ultrasonographer (midwife-sonographer or physician) to guide the procedure using a curved high-frequency probe. The following materials were required for the procedure: a sterile abdominal pack, an intramuscular needle, 20 mL of 1% lidocaine, a 20-mL syringe for the local anesthesia and a 20-gauge 15-cm amniocentesis needle (Echotip Amniocentesis needle, Cook Medical, Ireland). Under continuous ultrasound guidance, local anesthesia and aseptic conditions, the 20-gauge needle was inserted through an entry point that avoided the placenta and was directed towards the fetal anterior abdominal wall. The cyst was aspirated and drained completely or as much as possible. The aspirated liquid was quantified and its hormone (progesterone, estradiol, follicle-stimulating hormone, luteinizing hormone and testosterone) levels were assayed by radioimmunoassay in each participating maternity unit. The size and appearance of the cyst were verified after the procedure. A cyst was considered residual after the procedure if it then measured ≥ 30 mm. The fetal heart rate was monitored for 2 h after the procedure. Neither antibiotics nor tocolysis was administered systematically.
Ultrasound follow-up was similar for women in both groups and involved ultrasound monitoring every 2 weeks to evaluate the size (measuring the three largest diameters of the cyst) and ultrasound appearance of the cyst. No particular instructions were given for delivery of the women included in the trial. Ten days after birth, or earlier if the neonate showed symptoms, the size and appearance of the cyst (wall, shape, echogenicity) and the ovary were evaluated by transabdominal ultrasound examination.
Study outcomes
Primary outcome was need for any neonatal intervention, whether by laparoscopy, laparotomy or transabdominal aspiration, regardless of whether the operator proceeded to a simple exploration of the abdominal cavity, cystectomy, oophorectomy or salpingo-oophorectomy. Before commencement of the trial, surgeons in the participating units were interviewed to verify they agreed on the indications for intervention, which comprised: symptomatic cyst, cyst measuring ≥ 50 mm, non-involution of the cyst at 3 months postpartum and suspected ovarian torsion.
Secondary outcomes were in-utero involution of the cyst, defined as a reduction in size to < 30 mm, gestational age at delivery, rate of preterm birth, oophorectomy during surgery and involution of the cyst during the first 3 months postpartum.
Sample size
From a previous study conducted in our department, we estimated that 50% of neonates in the expectant management group would require a neonatal intervention 13 . A recent review also showed that conservative management of cysts was associated with 49% rate of postnatal surgery 11 . To reduce the intervention rate from 50% to 10% in the IUA group, setting the α and β risks at 5% and 20%, respectively, we calculated that 24 patients per group should be recruited. Given the risks of loss to follow-up and protocol deviations, we planned to recruit 30 patients in each group for a total of 60 women.
Statistical analysis
Descriptive analyses were performed for baseline characteristics. The IUA procedures and surgical procedures were described. To compare the main and secondary outcomes between the two groups, qualitative data were expressed as n (%) and compared using the χ 2 test (or Fisher's exact test, when appropriate), and quantitative data as mean or median with interquartile range and compared using Student's t-test. Results were also presented as relative risk (RR) with 95% CI. All analyses were conducted according to intention-to-treat principles (worst case scenario). Stata (13.1) software was used for statistical analyses (StataCorp LP, College Station, TX, USA). (Figure 1) . Of the 34 IUA procedures, one could not be performed because fetal position precluded access to the anterior part of the fetal abdominal wall, and two aspirations were dry.
RESULTS

Between
Characteristics of the study population are summarized in Table 1 . At inclusion, 43 (70%) cysts measured < 5 cm and only one measured > 8 cm. All aspiration procedures were uneventful, and only two women presented uterine contractions after the IUA, which did not lead to preterm delivery ( Table 2) .
Of fetuses whose cyst did not resolve before delivery, and who underwent ultrasound scan between inclusion and delivery, seven cysts from the IUA group and 14 from the expectant management group remained anechoic, four cysts (two in each group) had mobile internal echoes and one in the IUA group presented multiple septations.
One woman had complete regression of the cyst after IUA and was then lost to follow-up; we did not impute the missing data for the term of delivery but did apply the principle of 'worst case scenario' to the main outcome (imputation that the infant required a neonatal intervention).
In-utero aspiration (n = 34):
• Received allocated intervention (n = 31) • Dry aspiration (n = 2)
• Procedure not possible due to fetal position (n = 1)
Expectant management (n = 27):
• Received allocated intervention (n = 27) Seven (20.6%) neonates in the IUA group and 10 (37.0%) in the expectant management group underwent neonatal intervention (RR, 0.55; 95% CI, 0.24-1.27) ( Table 3) . IUA was associated with higher incidence of in-utero involution of the cyst (n = 16 (47.1%) vs n = 5 (18.5%); RR, 2.54; 95% CI, 1.07-6.05) and lower incidence of oophorectomy (n = 1 (3.0%) vs n = 6 (22.2%); RR, 0.13; 95% CI, 0.02-1.03). There was no difference between the two groups with regards to gestational age at delivery or incidence of preterm birth.
Seventeen surgical procedures were performed (Table 4) . Seven neonates underwent minilaparotomy (all to extract the cyst) and seven required oophorectomy or salpingo-oophorectomy.
DISCUSSION
IUA of fetal ovarian cysts did not lead to a significant reduction of neonatal interventions in our population. It was, however, associated with an increased incidence of in-utero involution of the cyst and a reduced risk of oophorectomy at birth. Recent reviews have pointed out the need for an adequately powered randomized controlled trial to ascertain the value of prenatal ovarian cyst aspiration 3, 11 . This is the first randomized trial to assess the efficacy and safety of IUA for anechoic fetal ovarian cysts. It is also the largest prospective series on this topic, including 61 fetuses with ovarian cysts. Other strengths of the study include its limitation to anechoic ovarian cysts and the stratification for cyst size. As shown in the latest review on this topic, size and appearance of the cyst are the two principal determinants of perinatal outcome for fetuses found to have ovarian cysts 3 . Because IUA is an invasive procedure, we had expected women to be reluctant to participate, but we reached the planned sample size in the expected time period of 4.5 years. We think this attests to the excellent information provided by, and communication skills of, the physicians responsible for recruitment in the different participating units. The investigators also felt that the discovery of a fetal ovarian cyst during ultrasound induces anxiety among future mothers and encourages them to accept this invasive procedure. During the study, the mothers allocated to the expectant management group were initially disappointed. We also note that the good ultrasound accuracy of the antenatal diagnosis of fetal ovarian cysts shows that the study took place in units with skilled, experienced sonographers.
Limitations of the study include the absence of an upper limit for gestational age at inclusion, which induced heterogeneity in our population as gestational age at inclusion and intervention ranged from 28 to 39 weeks. The median gestational ages in the two groups were fairly similar, but cysts diagnosed earlier during pregnancy may have a different prognosis from that of those discovered later. Nonetheless, an upper limit for gestational age at inclusion would likely create recruitment difficulties if another trial were to be considered.
We must emphasize, however, that in the efficacy assessment of IUA, there were almost twice as many neonatal interventions in the expectant management group than in the IUA group. Our negative results for the principal outcome could therefore be attributed to lack of power. The safety assessment showed that all aspiration procedures were uneventful and were not associated with an increased preterm birth rate; it is thus a safe procedure.
With respect to the main outcome, we note that while 'neonatal intervention' is an objective outcome, the decision to perform an intervention is not. Although the surgeons were reminded of the indications for Data are given as n (%), n/n (%) or median (interquartile range). *P calculated using Student's t-test, chi-square test or Fisher's exact test (F). †Data missing for one patient from in-utero aspiration group. neonatal intervention at the beginning of the trial, these indications may have differed from one department to another. Two physicians within the same department may make different decisions in the same medical situation; indeed, physicians frequently disagree about indications. Our outcome, therefore, is considered as one that is 'objectively measured but potentially influenced by clinician judgment', as defined by Savovic et al. 14 . Units with high intervention rates may have biased the results in favor of the IUA. The ideal outcome measure would have been the rate of ovarian torsion, but this can only be determined by macroscopic evaluation of the appearance of the residual ovary, which would be possible only through systematic laparoscopy of all neonates and thus would be ethically unacceptable. The need for a neonatal procedure appeared to us to be the most objective outcome, as the surgical indications for neonatal surgery are more or less consensual. These include symptomatic cysts, cysts measuring ≥ 50 mm or complex cysts (mobile internal echoes, a fluid-fluid level, multiple septations) 15 . Fetuses whose cysts had a complex ultrasound pattern at time of recruitment were not included as these imaging findings are highly predictive of ovarian torsion 16, 17 . Therefore, our trial did not address the problem of such complex cysts, for which a different study is needed to determine whether or not prenatal IUA can reduce neonatal morbidity.
Another strategy for the management of ovarian cysts is expectant management during pregnancy and transparietal aspiration in the early postpartum period 18 . This type of management, which has not been evaluated in a randomized trial, does not allow an assessment of the residual ovarian parenchyma, as opposed to neonatal surgery, and may increase the risk of ovarian torsion by delaying the intervention until after birth, as opposed to IUA.
Considering the low morbidity associated with IUA and the reduced rate of oophorectomy among the neonates in the IUA group, systematic IUA might well be worthwhile. Nearly 10% of the procedures could not be performed either due to fetal position precluding access to the cyst or because the aspiration was dry. When planning the study, a second aspiration attempt was not proposed, but if physicians consider the risk of torsion to be high the possibility of a second attempt should be considered.
In conclusion, IUA of anechoic fetal ovarian cysts, compared with expectant management, was not associated with either a reduction in overall neonatal intervention or an increased preterm birth rate. It was, however, associated with a reduced rate of oophorectomy.
